The Micropolis AI Robotics (NYSE: MCRP) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a foreign private issuer. Micropolis files reports with the U.S. Securities and Exchange Commission under the Exchange Act, including Form 6-K current reports and financial statements referenced in its registration materials.
Recent Form 6-K filings describe events such as the completion of its initial public offering of ordinary shares on the NYSE American, interim financial results for the six months ended June 30, 2025, and a securities purchase agreement involving a convertible promissory note and warrant. Other 6-Ks cover corporate governance and shareholder matters, including notices and proxy materials for extraordinary general meetings, voting results, and shareholder approval of a special resolution to change the company’s name from Micropolis Holding Company to Micropolis AI Robotics.
These filings also document material agreements, such as the securities purchase agreement with an institutional investor and related guaranty by a Micropolis subsidiary, along with the company’s obligations to file a Form F-1 registration statement for resale of conversion and warrant shares. Additional 6-Ks attach press releases that announce business developments, name-change timing, and meeting logistics.
On Stock Titan, users can review Micropolis’s 6-Ks and other available filings with AI-powered summaries that explain key terms, highlight significant changes, and clarify how each document relates to the company’s capital structure, governance, and operations. The page also surfaces important items such as interim financial disclosures and shareholder meeting outcomes, helping investors quickly understand the substance of lengthy regulatory documents without reading every line.
Micropolis AI Robotics (MCRP) extended the maturity of its $5,430,000 convertible promissory note with Streeterville Capital, LLC from October 21, 2026 to January 21, 2027. The amendment provides that no Trigger Event or Event of Default is deemed to have occurred because the outstanding balance was unpaid on October 21; the company paid or owes no fee, premium, increase in the outstanding balance, or other consideration for the amendment.
On October 22, 2026, the parties agreed to partition a new note with $10,000 in principal from the existing note and exchange it for 24,509 ordinary shares at $0.408 per share. The shares are subject to the note’s beneficial ownership limitation and exchange cap. The exchange is treated as an issuance of conversion shares under the Note, does not constitute a dilutive issuance, and does not give rise to an adjustment under the Warrant or Note; the company received no consideration other than surrender of the Partitioned Note.
Micropolis AI Robotics dismissed TAAD LLP as its independent registered public accounting firm, effective October 16, 2026, and appointed Mercurius & Associates LLP for the fiscal year ended December 31, 2025. TAAD had not completed its audit of the company’s consolidated financial statements for that year and will not issue a report on them. Mercurius is registered with the Public Company Accounting Oversight Board and will conduct the audit under its standards. Neither the company nor anyone acting on its behalf consulted Mercurius on the specified accounting, audit-opinion, disagreement, or reportable-event matters during the fiscal years ended December 31, 2024 and 2025, or the subsequent interim period through October 4, 2026.
Micropolis AI Robotics (MCRP) received notice that it does not meet NYSE American’s stockholders’ equity standard, which requires at least $4.0 million when a listed company reports losses from continuing operations and/or net losses in three of its four most recent fiscal years. The notice cited stockholders’ equity of $2.2 million as of June 30, 2025, and net losses in three of the four fiscal years ended December 31, 2024. The company intends to submit a plan by October 29, 2026, describing actions to regain compliance by March 29, 2028; acceptance is not assured. The notice itself is not a suspension of trading or a delisting determination, and the ordinary shares will continue trading on NYSE American. If the plan is not submitted or accepted, NYSE American will commence delisting proceedings. If accepted, the plan will be subject to periodic reviews, including quarterly monitoring; staff will initiate proceedings as appropriate if the company fails to make progress consistent with the plan or regain compliance by March 29, 2028. A below-compliance indicator will be disseminated five business days following receipt.
Micropolis AI Robotics (symbol MCRP) received a Schedule 13G from Alexander Rugaev disclosing his beneficial ownership of its Ordinary Shares. Rugaev reports owning 2,104,569 Ordinary Shares, representing 5.90% of the company’s outstanding Ordinary Shares as of August 21, 2026. He holds sole voting and sole dispositive power over all of these shares, with no shared voting or dispositive power. The filing notes that on September 14, 2023, before Micropolis AI Robotics’ initial public offering, he was issued 2,997,000 Ordinary Shares pursuant to a subscription. The 5.90% ownership calculation is based on 35,653,447 Ordinary Shares outstanding as of August 21, 2026.
Micropolis AI Robotics (MCRP) Schedule 13G shows Streeterville Capital LLC beneficially owns 3,485,355 ordinary shares, representing 9.99% of the class. The filing states the 9.99% cap arises from convertible note and warrant agreements and cites 34,888,447 shares outstanding as of January 16, 2026.
The report lists sole voting and dispositive power over the 3,485,355 shares and identifies Streeterville Management LLC and John M. Fife as related reporting persons.
Micropolis AI Robotics disclosed that NYSE American notified the company it is out of compliance after missing the May 15, 2026 deadline to file its 2025 Form 20-F for the year ended December 31, 2025. The exchange will monitor the overdue filing for an Initial Cure Period through November 15, 2026, with a possible Additional Cure Period to May 15, 2027 before suspension and delisting procedures generally begin. The delay stems from ongoing audit-related matters requiring more time to complete the 2025 financial statement audit. Micropolis is working with auditors and intends to file within the Initial Cure Period but cautions there is no assurance it will regain full listing compliance. The delinquency notice does not immediately affect trading, and the company’s ordinary shares remain listed on NYSE American during the cure period, subject to other listing requirements.
Micropolis AI Robotics reports a Schedule 13G showing Egor Romanyuk beneficially owns 5,509,000 Ordinary Shares. The filing states Mr. Romanyuk holds 15.45% of the outstanding Ordinary Shares based on 35,653,447 shares outstanding as of May 5, 2026. The filer reports sole voting and dispositive power over all 5,509,000 shares. The statement is signed on 05/12/2026.
Micropolis AI Robotics reports a 6.75% ownership stake held by Fares Mohd Said Mustafa Abubaker. The filing states Mr. Abubaker beneficially owns 2,407,011 Ordinary Shares. The filing also notes he acquired 2,999,999 Ordinary Shares on December 2, 2024 at a nominal price of $0.0001 per share. Shares outstanding are reported as 35,653,447 as of April 22, 2026. The reporting person has sole voting and dispositive power over the 2,407,011 shares.
MCRP submitted a Form 144 notice regarding proposed sales of Ordinary Shares. The filing lists 129,484 Ordinary Shares tied to a private placement dated 09/05/2020. It also records a past three‑month sale of 1,000 Ordinary Shares on 04/17/2026 at $2,650.00 per share. The page includes a numeric line of 30,000,000 with the date 04/21/2026 and NYSE American, presented as company/contextual information.
EXT LTD filed a Form 144 reporting dispositions of Ordinary Shares. The filing lists shares issued to founders of Micropolis AI Robotics on 08/23/2023 totaling 397,000 shares and discloses recent sales of 3,850 shares on 01/26/2026 for $10,972.00 and 3,000 shares on 02/27/2026 for $12,900.00.
Shares outstanding are shown as 35,288,447 as of 04/07/2026. The securities are listed on NYSE American. This filing is a routine Rule 144 disclosure of restricted/controlled share sales.